Assignee
CROSSWALK THERAPEUTICS INC
US·4 granted patents·3 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
7 records- 0189US12257291B2Human alpha-galactosidase variantsCROSSWALK THERAPEUTICS INC·Filed 2024·Granted Mar 25, 2025·0 cites·19 claims
- 0279US12497605B2Engineered acid alpha-glucosidase variantsCROSSWALK THERAPEUTICS INC·Filed 2024·Granted Dec 16, 2025·0 cites·20 claims
- 0375US12286655B2Human alpha-galactosidase variantsCROSSWALK THERAPEUTICS INC·Filed 2022·Granted Apr 29, 2025·0 cites·18 claims
- 0475US12263207B2Human alpha-galactosidase variantsCROSSWALK THERAPEUTICS INC·Filed 2021·Granted Apr 1, 2025·0 cites·33 claims
- 0574US2025179460A1Human alpha-galactosidase variantsCROSSWALK THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0668US2025207118A1Human alpha-galactosidase variantsCROSSWALK THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0766US2025002887A1Engineered acid alpha-glucosidase variantsCROSSWALK THERAPEUTICS INC·Filed 2024·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →